Goldman Sachs have had a buy rating with a target price of $42.90 for nearly 3 weeks now, wonder if they are going to re-rate or are confident with their last call in October?
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
I88 Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
